Sutro Biopharma, Inc.
STRO
$1.10
-$0.02-1.79%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -208.70M | -245.22M | -227.46M | -123.95M | -124.45M |
| Total Depreciation and Amortization | 7.47M | 7.36M | 7.22M | 7.08M | 7.02M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 34.95M | 26.81M | 19.80M | 8.09M | 28.80M |
| Change in Net Operating Assets | -82.58M | 16.37M | 8.90M | 3.05M | 13.92M |
| Cash from Operations | -248.86M | -194.68M | -191.54M | -105.73M | -74.72M |
| Capital Expenditure | -3.16M | -3.83M | -3.10M | -3.47M | -2.97M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 224.26M | 141.97M | 221.61M | 110.98M | -150.83M |
| Cash from Investing | 221.10M | 138.15M | 218.51M | 107.51M | -153.80M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | -4.08M | -7.21M | -10.33M |
| Issuance of Common Stock | 1.34M | 97.86M | 98.65M | 98.65M | 98.51M |
| Repurchase of Common Stock | -338.00K | -315.00K | -509.00K | -485.00K | -444.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | -3.54M |
| Cash from Financing | 999.00K | 97.55M | 94.05M | 90.95M | 84.20M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.76M | 41.01M | 121.02M | 92.73M | -144.32M |